Cargando…
Emerging Targeted Therapy for Specific Genomic Abnormalities in Acute Myeloid Leukemia
We describe recent updates of existing molecular-targeting agents and emerging novel gene-specific strategies. FLT3 and IDH inhibitors are being tested in combination with conventional chemotherapy for both medically fit patients and patients who are ineligible for intensive therapy. FLT3 inhibitors...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879537/ https://www.ncbi.nlm.nih.gov/pubmed/35216478 http://dx.doi.org/10.3390/ijms23042362 |